These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


62 related items for PubMed ID: 3527954

  • 1. [Dermatologic lesions in renal transplant patients treated with low doses of steroids].
    Manganoni MA, Calzavara Pinton PG, Gavazzoni R, Graifemberghi S, Manganoni A, Scolari F.
    G Ital Dermatol Venereol; 1986; 121(3):187-9. PubMed ID: 3527954
    [No Abstract] [Full Text] [Related]

  • 2. The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.
    Moloney FJ, Dicker P, Conlon PJ, Shields DC, Murphy GM.
    Br J Dermatol; 2006 Jun; 154(6):1199-200. PubMed ID: 16704656
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Incidence of cytomegalovirus infections in renal transplant patients treated with conventional or cyclosporin therapy.
    Guerin C, Pozzetto B, Genin C, Berthoux FC, Gaudin OG.
    Nephrol Dial Transplant; 1988 Jun; 3(1):77-80. PubMed ID: 2837679
    [Abstract] [Full Text] [Related]

  • 5. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine.
    Dunn JF, Hatch J, Precht A, Hart M, Li S.
    Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479
    [No Abstract] [Full Text] [Related]

  • 6. Cutaneous complications of immunosuppressive therapy. A review of 215 renal transplant patients.
    Bergfeld WF, Roenigk HH.
    Cutis; 1978 Aug; 22(2):169-72. PubMed ID: 357092
    [No Abstract] [Full Text] [Related]

  • 7. Effects of the new immunosuppressive agents on the occurrence of malignancies after renal transplantation.
    Marcén R, Galeano C, Fernández-Rodriguez A, Jiménez-Alvaro S, Teruel JL, Rivera M, Burgos FJ, Quereda C.
    Transplant Proc; 2010 Oct; 42(8):3055-7. PubMed ID: 20970609
    [Abstract] [Full Text] [Related]

  • 8. Unusual cutaneous infections associated with immunosuppressive therapy.
    Park RK, Goltz RW, Carey TB.
    Arch Dermatol; 1967 Apr; 95(4):345-50. PubMed ID: 6023039
    [No Abstract] [Full Text] [Related]

  • 9. Renal transplantation, immunosuppression and the skin: an update.
    Moloney FJ, de Freitas D, Conlon PJ, Murphy GM.
    Photodermatol Photoimmunol Photomed; 2005 Feb; 21(1):1-8. PubMed ID: 15634217
    [Abstract] [Full Text] [Related]

  • 10. Impact of symptom frequency and symptom distress on self-reported quality of life in heart transplant recipients.
    Lough ME, Lindsey AM, Shinn JA, Stotts NA.
    Heart Lung; 1987 Mar; 16(2):193-200. PubMed ID: 3546207
    [No Abstract] [Full Text] [Related]

  • 11. Cutaneous complications in immunosuppressed renal homograft recipients.
    Koranda FC, Dehmel EM, Kahn G, Penn I.
    JAMA; 1974 Jul 22; 229(4):419-24. PubMed ID: 4275980
    [No Abstract] [Full Text] [Related]

  • 12. Hypertension in renal transplant recipients on cyclosporin A and corticosteroids and azathioprine.
    Hamilton DV, Carmichael DJ, Evans DB, Calne RY.
    Transplant Proc; 1982 Sep 22; 14(3):597-600. PubMed ID: 6758243
    [No Abstract] [Full Text] [Related]

  • 13. [Chronic myeloid leukemia after renal transplantation: report of a new case and review of the bibliography].
    Sanz L, Cervantes F, Esteve J, Vilardell J, Marín P, Rozman C, Montserrat E.
    Sangre (Barc); 1996 Oct 22; 41(5):391-3. PubMed ID: 9026925
    [Abstract] [Full Text] [Related]

  • 14. Rectal malacoplakia in a renal transplant recipient.
    Ourahma S, Barrou B, Bitker MO, Sylla C, Mouquet C, Chatelain C.
    Transplant Proc; 1996 Oct 22; 28(5):2824. PubMed ID: 8908081
    [No Abstract] [Full Text] [Related]

  • 15. [Kaposi's angiosarcoma in a renal transplant patient].
    Martí R, Bou D, Torras H.
    Actas Dermosifiliogr; 1981 Oct 22; 72(5-6):215-8. PubMed ID: 7032247
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
    de Graaf YG, Rebel H, Elghalbzouri A, Cramers P, Nellen RG, Willemze R, Bouwes Bavinck JN, de Gruijl FR.
    Exp Dermatol; 2008 Apr 22; 17(4):349-55. PubMed ID: 17979968
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Skin manifestations in 140 kidney transplants].
    Lesnoni La Parola I, Citterio F, Nanni G, Serino F, Borzi MT, Rotoli M.
    Recenti Prog Med; 1992 Feb 22; 83(2):61-3. PubMed ID: 1502419
    [Abstract] [Full Text] [Related]

  • 20. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI, Flechner SM, Van Buren CT, Kerman RH, Kahan BD.
    Transplant Proc; 1985 Aug 22; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.